Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

Y
Yabe M. - GENETIC FACTORS FOR DETERMINATION OF PLASMA VWF LEVELS IN A GENERAL POPULATION
  - EFFECT OF HUMAN TERT TRANSFECTION ON GENE EXPRESSION PROFILING IN NORMAL HUMAN CORONARY ARTERY ENDOTHELIAL CELLS
Yacobovich J. - ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Yago H. - NEW LATEX-ENHANCED IMMUNOTURBIDIMETRY ASSAY WITH UNIQUE MONOCLONAL ANTIBODY TO SPECIFIC EPITOPES MEASURES SOLUBLE FIBRIN
Yakovlev S. - DIRECT EVIDENCE OF SPECIFIC INTERACTIONS OF FIBRINOGEN ALPHA C REGIONS WITH THE CENTRAL E REGION AND WITH EACH OTHER
  - IDENTIFICATION OF A NOVEL ENDOTHELIAL CELL RECEPTOR FOR FIBRIN
Yamada Y. - QUANTIFICATION OF BLOOD COAGULATION FACTOR XIII ANTIGEN BY LATEX IMMUNOTURBIDIMETRIC ASSAY
Yamada T. - REDUCTION OF ANTI-FIX INHIBITOR TITER IN A HEMOPHILIA B PATIENT WITH CONTINUOUS USE OF APCC
  - FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
Yamada K. - THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR
Yamada T. - MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
Yamada N. - ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS
Yamada S. - CLINICAL SIGNIFICANCE OF HMGB-1, SF AND PAI-1 AS A VITAL- PROGNOSIS MARKER
Yamaki T. - DOES DIFFERENT D-DIMER LEVEL REDUCE THE USE OF VENOUS DUPLEX SCANNING TO RULE OUT DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM?
  - PREVALENCE AND DISTRIBUTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM
  - THE UTILITY OF QUANTITATIVE CALF MUSCLE NEARINFRARED SPECTROSCOPY IN THE FOLLOWUP OF ACUTE DEEP VEIN THROMBOSIS
Yamamoto K. - THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Yamamoto T. - THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR
Yamamoto K. - FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
Yamamoto H. - LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
  - PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
Yamamoto Y. - CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Yamamoto K. - MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
Yamamoto T. - PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
Yamamoto J. - PLATELET DELAY TIME AS MEASURED IN THE ARTERIOLES OF RATS USING LASER INDUCED THROMBOSIS
Yamashita A. - MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
Yamashita T. - PLATELET DELAY TIME AS MEASURED IN THE ARTERIOLES OF RATS USING LASER INDUCED THROMBOSIS
Yamashita A. - PLATELET IS AN IMPORTANT FACTOR IN VENOUS THROMBOEMBOLISM: INTERACTION OF VON WILLEBRAND FACTOR AND PLATELET GPIB PROMOTES VENOUS THROMBUS GROWTH
Yamashita M. - PARATOPE AND EPITOPE MAPPING OF THE ANTITHROMBOTIC ANTIBODY 6B4 IN COMPLEX WITH PLATELET GLYCOPROTEIN IBALPHA
Yamashita D. - EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
Yamashita Y. - EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
Yamashita S. - INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
Yamashita A. - FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13
  - ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS
Yamauchi T. - INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
Yamazaki Y. - IDENTIFICATION OF VEGF RECEPTOR-BINDING SITES OF KDR-BINDING PROTEIN
  - AUGMENTATION OF VASCULAR PERMEABILITY OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IS ENHANCED BY VEGF RECEPTOR 2-BINDING PROTEINS
Yamazaki M. - CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES
Yamazaki Y. - MOLECULAR AND FUNCTIONAL DIVERSITY OF SNAKE VENOM VEGFS
Yamazaki T. - THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Yamazaki M. - PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
Yamazaki T. - ALLELIC FREQUENCY AND MINOR VARIATIONS OF THE FACTOR V R2 HAPLOTYPE IN JAPANESE POPULATION
  - DIFFERENTIAL DETECTION OF WILD-TYPE AND MUTANT MYH9 MRNA AND NMMHC-IIA POLYPEPTIDE REVEALS DOMINANT-NEGATIVE EFFECT IN GRANULOCYTES AND HAPLOINSUFFICIENCY IN PLATELETS IN PATIENTS WITH MYH9 DISORDERS
Yan X. - BETA 2 GLYCOPROTEIN I PROTECTS THROMBIN FROM INHIBITION BY HEPARIN COFACTOR II: LOSS OF ACTIVITY BY PROTEOLYTICALLY CLIPPED BETA 2 GLYCOPROTEIN I
Yan Z. - VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
Yancheva E. - EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD
Yang R. - INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
  - THE HUMAN DNMTS1,3A AND 3B MRNA EXPRESSION IN ADULT ITP PATIENTS
Yang J. - THE DISTAL CARBOXYL-TERMINAL DOMAINS OF ADAMTS13 ARE REQUIRED IN VIVO FOR EFFICIENT CLEAVAGE OF VON WILLEBRAND FACTOR UNDER PROTHROMBOTIC CONDITIONS
Yang H. - IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)
Yang X.V. - ACTIVATED PROTEIN C (APC) REQUIRES RESIDUES 176-178 FOR NORMAL ANTICOAGULANT, ANTI-APOPTOTIC AND ANTI-INFLAMMATORY ACTIVITIES
  - DISSECTION OF STRUCTURAL REQUIREMENTS FOR ACTIVATED PROTEIN C ANTICOAGULANT VERSUS CYTOPROTECTIVE ACTIVITIES
Yang Z. - HYPERACTIVE C-JUN N-TERMINAL KINASE ENHANCES VASCULAR TISSUE FACTOR EXPRESSION IN AGING
Yang Y. - IMPAIRED RESPONSIVENESS OF PLATELETS TO EPINEPHRINE IN CHINESE RELATED TO A2A ADRENOCEPTOR POLYMORPHISMS
Yang F. - GENETIC ANALYSIS OF HEREDITARY PROTEIN S DEFICIENCY IN TWO CHINESE PEDIGREES
Yang H. - ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
Yang Y.L. - SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
Yang F. - ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED WITH MULTIPLE COAGULATION FACTOR DEFICIENCY IN SEVEN CHINESE PATIENTS
Yang R. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Yang F. - THREE NOVEL MUTATIONS OF ANTITHROMBIN GENE WERE IDENTIFIED IN CHINESE FAMILIES
Yang R. - SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Yang J. - GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Yang L. - THE RECEPTORS OF PROTEIN C ACTIVATION AND ACTIVATED PROTEIN C SIGNALING PATHWAYS ARE CO-LOCALIZED IN LIPID RAFTS OF ENDOTHELIAL CELLS
Yang H. - FLUVASTATIN INHIBITS REGULATED SECRETION OF ENDOTHELIAL CELL VON WILLEBRAND FACTOR IN RESPONSE TO DIVERSE SECRETAGOGUES
Yang R. - CD72 POLYMORPHISM ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC THROMBOCYTOPENIA PURPURA IN CHINESE PATIENTS
Yanilmaz O. - THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
  - FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
  - EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
Yaniv I. - ISRAELI PEDIATRIC ONCOLOGY REGISTRY ON CENTRAL VENOUS LINE RELATED COMPLICATIONS
Yao G. - SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
Yarnold P. - ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
Yarranton H. - SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
Yasar Z. - MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS
Yashiro K. - THE EFFECTS OF BLOCKING P2Y12 RECEPTOR IN ARTEROSCLEROSIS PRODUCED BY MURINE ALLO-TRANSPALANTATION
Yassin D. - THE EFFECT OF TEST CONDITIONS ON THROMBOELASTOGRAPHY PARAMETERS IN HEMOPHILIACS WITH AND WITHOUT INHIBITORS
Yassine J. - EFFICACY OF WHOLE BLOOD PLATELET AGGREGATION IN THE EVALUATION OF BLEEDING OR THROMBOTIC TENDENCIES
Yasuda S. - THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY
Yasuda H. - GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Yasuda S. - DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
Yatagai C. - ISOFLAVONE GENISTEIN AND ITS ANALOGUES ENHANCED T-PA PRODUCING ACTIVITY OF HELA S3
  - INCREASE IN NATTOKINASE ACTIVITY AND VITAMIN K2 CONTENT CAUSED BY DIPICOLINIC ACID
Yatagai Y. - IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Yatomi Y. - ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION
  - SYNERGISM BETWEEN GI ACTIVATION AND CA2+ MOBILIZATION IN PLATELET THROMBOXANE A2 FORMATION
  - CLEC-2, A NOVEL PLATELET ACTIVATION RECEPTOR, IS INVOLVED IN PODOPLANIN-MEDIATED PLATELET ACTIVATION BY CANCER CELLS
Yatsenko E. - HAEMORRHAGES SYMPTOMS IN GIRL WITH FACTOR XII SEVERE DEFICIENCY
Yavarian M. - INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Ye P. - ANTI-ICOS IMMUNOTHERAPY PREVENTED INHIBITORY ANTIBODY FORMATION AGAINST FACTOR VIII FOLLOWING NONVIRAL GENE TRANSFER IN HEMOPHILIA A MICE
Ye X. - A SURVEY ON THE PREVALENCE OF VENOUS THROMBOEMBOLIC DISEASES IN GUANGZHOU OF CHINA
Ye H. - EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO
Ye X. - CLINICAL APPLICATION OF ACTIVATED RECOMBINANT HUMAN FACTOR ? IN CHINA
Yee D.L. - PREVALENCE OF "ASPIRIN RESISTANCE" IN CHILDREN
  - ANTITHROMBOTIC THERAPY IN INFANTS WITH SVC SYNDROME: ADDITIONAL MODALITIES ARE REQUIRED
Yegneswaran S. - GLYCOPROTEIN IB ALPHA BINDS THROMBIN VIA TO BOTH EXOSITE I AND II OF THROMBIN
  - THROMBIN BINDING TO GLYCOPROTEIN IB ALPHA ON PLATELETS INVOLVES EXOSITE I
  - RESIDUES 311-325 ON THE HEAVY CHAIN OF FVA REPRESENT AN ACTIVATED PROTEIN C BINDING REGION
Yelamos J. - IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN
Yevdokimova N. - TGFBETA1 IS RESPONSIBLE FOR HIGH-GLUCOSE-INDUCED ENRICHMENT OF PERICELLULAR MATRIX WITH HYALURONIC ACID. DIFFERENT MECHANISMS FOR ENDOTHELIAL AND MESANGIAL CELLS
Yi C.H. - THE SCREENING ASSAY OF PLATELET- ASSOCIATED IMMUNOGLOBULIN G CAN NOT IMPROVE THE SENSITIVITY OF MONOCLONAL ANTIBODY IMMOBILIZATION OF PLATELET ANTIGENS ASSAY IN IMMUNE THROMBOCYTOPENIC PURPURA
Yigitbasi O. - INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
Yildirim H. - INTRACRANIAL THROMBOSIS COMPLICATING THE MANAGEMENT OF HEMOPHILIC ARTHROPATHY: ANTICOAGULANT TREATMENT IN A CASE WITH HEMOPHILIA B
Yildirmaz S. - USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY
Yilmaz D. - RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
Yin T. - A LARGE DELETION OF THE PROS1 GENE IN A DEEP VEIN THROMBOSIS PATIENT WITH PROTEIN S DEFICIENCY
Yin O. - TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
Yin J. - SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
Yin M. - COMPARISON OF EFFICACY AND SAFETY OF INTRAVENOUS AND INTRA-ARTERIAL THROMBOLYSIS IN ACUTE ISCHEMIC STROKE
Yin H. - THE LEECH PRODUCT SARATIN IS A POTENT INHIBITOR OF PLATELET INTEGRIN ALPHA2BETA1 AND VWF BINDING TO COLLAGEN
Yip Y.Y. - ANTICOAGULANT EFFECT OF DANAPAROID, FONDAPARINUX, AND LEPIRUDIN IN CHILDREN COMPARED TO ADULTS
Yndestad A. - ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Yocum A. - IDENTIFICATION OF NOVEL PLATELET MEMBRANE PROTEINS USING MULTI-DIMENSIONAL PROTEIN IDENTIFICATION TECHNOLOGY
Yohann R. - IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS
Yoho J. - INHIBITION OF PLATELET AGGREGATION: A NOVEL EFFECT OF C-REACTIVE PROTEIN
Yokohama H. - EFFECTS OF E5555, A PROTEASE-ACTIVATED RECEPTOR-1 ANTAGONIST, ON THE INFLAMMATORY MARKERS IN VITRO
Yokouchi Y. - FLOW CYTOMETRIC ANALYSIS OF VASP PHOSPHORYLATION IN PLATELETS TREATED WITH THE ACTIVE METABOLITE OF PRASUGREL, A P2Y12 ADP RECEPTOR ANTAGONIST
  - COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140
Yokoyama K. - ULTRASTRUCTURAL ANALYSIS OF CULTURED MEGAKARYOCYTES GROWN FROM BONE MARROW MONONUCLEAR CELLS OF A NEWLY DIAGNOSED JAPANESE PATIENT WITH GRAY PLATELET SYNDROME
Yonemitsu Y. - VEGF FUNCTION FOR UPREGULATION OF ENDOGENOUS PLGF EXPRESSION DURING FGF-2-MEDIATED THERAPEUTIC ANGIOGENESIS
  - ROLE OF ANGIOPOIETIN(ANG)-1/TIE-2 SIGNALING PATHWAY FOR ANG-2 EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Yonemura M. - CLINICAL SIGNIFICANCE OF HMGB-1, SF AND PAI-1 AS A VITAL- PROGNOSIS MARKER
Yonemura Y. - ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
Yong L.S. - PHARMACO-ECONOMIC EVALUATION OF TREATMENT ALTERNATIVES FOR MILD TO MODERATE BLEEDING EPISODES IN PATIENTS WITH HAEMOPHILIA WITH INHIBITORS IN KOREA
Yong S. - MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
Yong G. - COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYRO THROMBOXANE B2
Yoo H. - CERAMIDE KINASE/CERAMIDE 1-PHOSPHATE IS AN IMPORTANT REGULATOR ON AORTIC VASCULAR SMOOTH MUSCLE CELL PROLIFERATION
  - ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
Yoo S.K. - PHARMACO-ECONOMIC EVALUATION OF TREATMENT ALTERNATIVES FOR MILD TO MODERATE BLEEDING EPISODES IN PATIENTS WITH HAEMOPHILIA WITH INHIBITORS IN KOREA
Yoon H. - GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
Yoon B. - COST-EFFECTIVENESS (CE) OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) VS. RECOMBINANT FVIIA IN PROPHYLAXIS IN HEMOPHILIA PATIENTS WITH INHIBITORS
Yoon S. - THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Yoon B.S. - ASSESSMENT OF THROMBOTIC ADVERSE EVENTS (TAES) WITH ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES (APCCS): 17 YEAR EXPERIENCE
Yoon B. - HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING MAJOR ORTHOPEDIC SURGERIES: COST-MINIMIZATION ANALYSIS OF ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) AND RECOMBINANT FVIIA
Yoon H.J. - IMMUNE TOLERANCE INDUCTION FOR KOREAN HEMOPHILIACS WITH INHIBITORS
Yoshida E. - ISOFLAVONE GENISTEIN AND ITS ANALOGUES ENHANCED T-PA PRODUCING ACTIVITY OF HELA S3
Yoshikawa T. - REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Yoshitome S. - IDENTIFICATION OF MULTIPLE SPLICE VARIANTS OF PHOSPHOLIPID SCRAMBLASE 1
Young B.A. - A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS
Young A. - VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
Young L.K. - CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI
Young G. - THE EFFECT OF TEST CONDITIONS ON THROMBOELASTOGRAPHY PARAMETERS IN HEMOPHILIACS WITH AND WITHOUT INHIBITORS
Young S.G. - REVERSAL OF HYPERCHOLESTEROLEMIA PROTECTS AGAINST ARTERIAL THROMBOSIS IN ATHEROSCLEROTIC MICE
Young M. - SF-12 PHYSICAL COMPONENT SCORE IS AN INDEPENDENT PREDICTOR OF MAJOR HEMORRHAGE IN A COHORT OF ELDERLY PATIENTS ANTICOAGULATED FOR ATRIAL FIBRILLATION
Young B.A. - GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
  - FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS
Yu J. - POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
  - ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
Yu Z. - APIXABAN, AN ORAL DIRECT FACTOR XA INHIBITOR: MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
  - A HETEROZYGOUS MUTATION OF GPIIB IN PATIENT WITH GLANZMANN THROMBASTHENIA
Yu J. - ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Yu I. - KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
Yu Z. - EXPOSURE-CLINICAL OUTCOME MODELING AND SIMULATION TO FACILITATE DOSE SELECTION OF APIXABAN IN SUBJECTS UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT SURGERY
Yu J. - TALIN HEAD-ROD INTERACTION MODULATES INTEGRIN BINDING TO THE TALIN HEAD DOMAIN
  - EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
Yu I. - CHARACTERIZATION OF VASCULAR ENDOTHELIAL CELLS WITH NULL THROMBOXANE A2 SYNTHASE
Yu Z. - APIXABAN, AN ORAL DIRECT, FACTOR XA INHIBITOR: SINGLE-DOSE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
Yuan Y. - MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
Yuan S. - A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Yudkin J.S. - PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
Yuki S. - ROLE OF THE PROAPOPTOTIC BH3-ONLY PROTEIN BIM IN MEGAKARYOPOIESIS AND PLATELET PRODUCTION
  - PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
  - POSSIBLE INVOLVEMENT OF CD226 IN CELLULAR INTERACTION OF MEGAKARYOCYTES WITH ENDOTHELIAL CELLS DURING MEGAKARYOPOIESIS AND PLATELET PRODUCTION
Yuksel M. - INCIDENCE OF ANTI-HEPARIN/PLATELET FACTOR 4 (AHPF4) ANTIBODIES AND HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IN MEDICAL PATIENTS
Yun Y. - OBOVATOL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMAL FORMATION AFTER CAROTID INJURY IN RATS
  - ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
  - EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
  - POTENT INHIBITION OF PDGF-BB-STIMULATED RESPONSES IN VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY CUDRATRICUSXANTHONE A ISOLATED FROM THE ROOT BARK OF CUDRANIA TRICUSPIDATA
  - CERAMIDE KINASE/CERAMIDE 1-PHOSPHATE IS AN IMPORTANT REGULATOR ON AORTIC VASCULAR SMOOTH MUSCLE CELL PROLIFERATION
  - ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
  - EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
  - ANTIPROLIFERATIVE ACTIVITY OF YQN1, A NEWLY SYNTHESIZED INDOLEDIONE DERIVATIVE, ON PDGF-BB-STIMULATED AORTIC VASCULAR SMOOTH MUSCLE CELLS
Yun-Choi H. - THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Yun-Choi H.H.S. - CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Yun-Hua C. - FROM HEMATOPOIETIC STEM CELLS TO PLATELETS
Yürürer D. - SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND CYTOKINE LEVELS IN TURKISH PEDIATRIC STROKE PATIENTS
Yusen R.D. - DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM
  - LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
Yusova E.I. - INFLUENCE OF THE STREPTOKINASE 36 KDA FRAGMENT ON THE PLASMIN ACTIVITY
Yuste V.J. - SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
  - NEW THERAPEUTIC APPROACH IN ACQUIRED HEMOFILIA
  - PROPHYLAXIS WITH RECOMBINANT FVIIA
  - PRIMARY PROPHYLAXIS WITH RECOMBINANT FACTOR VIIA IN A PATIENT WITH HAEMOPHILIA A AND INHIBITOR
  - ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
| ISTH 2009